Michael Sukkar MP visits Trajan Headquarters

Michael Sukkar MP visits Trajan Headquarters

February 04, 2015

Trajan's global headquarters located in Ringwood, Melbourne, was visited by Michael Sukkar MP, Member for Deakin, Parliament of Australia on 4 February, 2015.

Mr Sukkar was pleased to tour a growing local advanced manufacturing facility, with Trajan exporting products used in scientific and medical analysis to customers in over 100 countries.

In the past, Trajan's SGE Analytical Science brand of chromatography consumables has been awarded an R&D100 Technology Innovation Award, Victorian Exporter of the Year and inducted into Victoria’s Manufacturing Hall of Fame.

Apart from the production of specialized components, Trajan also services the local Australian clinical and medical research sectors with a wide range of pathology consumables through its Grale HDS brand.

Mr Sukkar said it was a privilege to visit Trajan’s headquarters in Ringwood and hear the inspirational story behind this growing business.

“Stephen Tomisich and his team are at the forefront of analytical and medical science, developing and commercializing technologies that will make a real difference to the health and well-being of our nation,” he said.

“I look forward to visiting again soon and supporting this business as it continues to go from strength to strength.”

Chief Executive Officer of Trajan Stephen Tomisich said "It was a great opportunity to share our journey so far, and how we plan to contribute to a strong future of technology innovation and manufacturing in Australia."

Photo: Trajan's CEO Stephen Tomisich (right) explaining the critical features of an analytical syringe to Michael Sukkar MP (left).




Also in News

Trajan completes ISO 9001 recertification
Trajan completes ISO 9001 recertification

July 14, 2021

Trajan Scientific and Medical has successfully completed a 3-year ISO 9001:2015 recertification at our Ringwood global headquarters this week, cementing the importance that we place over quality management and continuous improvement for ourselves and all stakeholders.

Read More

Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth
Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth

May 17, 2021

Global analytical science and device company Trajan Group Holdings Limited (Trajan or the Company) has launched a $90 million IPO to support the next phase of accelerated growth.

Read More

Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare
Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare

April 16, 2021

Trajan Scientific and Medical (Trajan) has completed the acquisition of the MyHealthTest blood testing service for an undisclosed sum. The acquisition further boosts Trajan’s ability to deliver analytical measurement services to society at a time when preventative healthcare strategies are becoming increasingly important.

Read More